Exagen Inc.

NASDAQ: XGN · Real-Time Price · USD
9.70
0.35 (3.80%)
At close: Aug 15, 2025, 3:59 PM
9.49
-2.11%
After-hours: Aug 15, 2025, 04:18 PM EDT

Exagen Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
30.03M 11.19M 22.04M 22.04M 24.48M 27.27M 36.49M 28.45M 31.47M 52.18M 62.39M 68.7M 76.39M 89.75M 99.44M 106.77M 112.58M 118.05M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a n/a 200K 200K 200K 200K n/a 200K 200K 100K 100K 100K 100K 100K 100K
Other Long-Term Assets
1.26M 596K 550K 563K 513K 361K 416K 438K 420K 603K 528K 586K 625K 701K -391K 439K 235K 269K
Receivables
14.27M 14.73M 7.83M 9.39M 11.7M 10.9M 6.55M 17.04M 16.23M 9.3M 6.08M 10.64M 9.59M 10.91M 9.65M 9.21M 8.78M 8.22M
Inventory
n/a n/a n/a n/a 2.87M 2.1M 2.87M 2.24M 1.65M n/a 1.79M 1.36M 1.99M 1.98M 1.09M 1.4M 2.19M 2.18M
Other Current Assets
6.68M 6.58M 6.58M n/a n/a n/a n/a n/a n/a 244K n/a n/a -1.08M -998K n/a 1.31M 1.41M 1.14M
Total Current Assets
50.99M 32.51M 36.45M 35.56M 40.79M 42.4M 47.84M 48.91M 51.27M 65.72M 72.61M 82.06M 89.04M 103.64M 112.73M 118.38M 124.53M 129.37M
Property-Plant & Equipment
6.51M 7.19M 7.68M 7.49M 8M 7.85M 8.49M 11.38M 12.29M 12.91M 13.08M 13.45M 12.55M 12.2M 4.77M 3.45M 3.05M 2.38M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.61M 5.51M 5.51M 5.51M 5.51M 5.51M 5.51M 5.51M
Total Long-Term Assets
7.77M 7.79M 8.23M 8.05M 8.51M 8.41M 9.1M 12.02M 12.91M 13.52M 13.61M 19.54M 18.68M 18.41M 10.71M 9.39M 8.79M 8.15M
Total Assets
58.76M 40.29M 44.69M 43.6M 49.31M 50.81M 56.94M 60.93M 64.18M 79.23M 86.22M 101.6M 107.72M 122.04M 123.44M 127.77M 133.32M 137.52M
Account Payables
2.51M 4.51M 4.14M 1.1M 2.33M 1.47M 3.13M 1.66M 1.31M 1.88M 3.05M 3.67M 3.1M 4.21M 2.49M 1.51M 2.45M 2.17M
Deferred Revenue
1.02M 876K n/a n/a 1.25M n/a n/a n/a 5.68M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Short-Term Debt
1.83M 3.66M 423K 430K 423K 268K 264K 261K 257K 254K 190K n/a n/a n/a n/a n/a n/a n/a
Other Current Liabilities
7.45M 4.95M 7.65M n/a 1.52M 1.89M 2.3M 2.86M 254K 445K 2.29M 2.57M 1.91M 2.77M 2.19M 2.21M 1.78M 2M
Total Current Liabilities
10.29M 13.99M 13.51M 8.78M 9.45M 8.78M 11.9M 10.12M 8.6M 9.27M 9.62M 11.33M 9.57M 11.88M 9.32M 8.1M 8.27M 7.88M
Long-Term Debt
1.07M 1.37M 19.82M 19.82M 19.83M 19.27M 19.23M 19.19M 19.15M 29.09M 28.78M 28.01M 27.83M 27.65M 27.48M 27.29M 27.07M 26.86M
Other Long-Term Liabilities
26.36M 122K 157K 185K 219K 268K 357K 484K 597K 726K 867K 999K 810K 763K 1.41M 1.43M 1.45M 1.15M
Total Long-Term Liabilities
27.43M 19.9M 21.64M 21.96M 22.28M 22.03M 22.35M 23.3M 23.67M 34.03M 34.14M 34.08M 33.97M 34M 29.19M 28.87M 28.68M 28.17M
Total Liabilities
37.73M 33.89M 35.15M 30.74M 31.72M 30.82M 34.25M 33.42M 32.28M 43.3M 43.76M 45.41M 43.54M 45.89M 38.51M 36.97M 36.94M 36.05M
Total Debt
2.89M 5.03M 23.36M 23.27M 23.88M 23.48M 23.72M 24.22M 24.44M 35.28M 34.5M 33.78M 34.51M 34.48M 27.48M 27.87M 27.62M 27.26M
Common Stock
22K 18K 18K 18K 17K 17K 17K 17K 17K 17K 17K 16K 16K 16K 16K 16K 16K 17K
Retained Earnings
-302.52M -298.08M -294.33M -290.57M -285.54M -282.58M -279.22M -273.64M -268.23M -263.21M -255.53M -241.17M -231.72M -218.41M -208.14M -201.09M -193.91M -187.5M
Comprehensive Income
n/a n/a n/a n/a n/a n/a 0.00 n/a n/a n/a -0.00 n/a n/a -0.00 n/a -0.00 -0.00 -0.00
Shareholders Equity
21.03M 6.4M 9.54M 12.87M 17.59M 19.99M 22.69M 27.5M 31.9M 35.94M 42.46M 56.19M 64.18M 76.16M 84.94M 90.8M 96.38M 101.47M
Total Investments
n/a n/a n/a n/a 200K 200K 200K 200K 200K n/a 200K 200K 100K 100K 100K 100K 100K 100K